Archive - Lưu Trữ Tin Tức - Archive - English News Paper

Gene Therapy

Gene Therapy: 2026August14Friday

PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program - PR Newswire

PTC takes a chance on Sangamo’s Fabry disease gene therapy - biopharmadive.com

PTC’s $211M bid wins Sangamo auction, teeing up ‘special opportunity’ to enter Fabry market - Fierce Biotech

Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale - BioSpace

Bankrupt Sangamo scores at least $163 million in asset sale, which had two big winners - The Business Journals

PTC Therapeutics, Lilly to buy up bits of Sangamo in bankruptcy auction - Endpoints News

CRISPR roadblocks: Scientists identify genes blocking gene therapy success - Phys.org

Skylark Bio kicks off new gene therapy trial for deafness - STAT

Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety - STAT

Lilly drops another gene therapy trial from $1B Prevail buyout - Fierce Biotech

Cancer Treatment: 2026August14Friday

'Game changer' drug gives new hope in pancreatic cancer fight - usatoday.com

An Experimental Pediatric Cancer Treatment Shows Promise in New Research - Time Magazine

Cancer Patients Are Being Forced to Wait Longer Before Treatment: Study - People.com

Cancer patients are waiting longer to start treatment than they did a decade ago, study finds - PhillyVoice

Cancer patients face longer wait times to begin treatment, according to new study - STAT

US FDA approves Bristol Myers' blood cancer treatment - Reuters

mRNA immunotherapy developed by UMass Chan scientists eliminates pancreatic tumors in mice - UMass Chan Medical School

RSC postpones Othello while leading actor Sharon D Clarke has cancer treatment - The Guardian

Sharon D Clarke Postpones RSC Othello for Cancer Treatment - Playbill

‘Othello’ Royal Shakespeare Company Adaptation Starring Sharon D. Clarke Postponed as She Undergoes Cancer Treatment - Variety

T-cell Therapy: 2026August14Friday

In vivo genome-wide CRISPR screens of human T cells in solid tumours - Nature

Personalized T-cell therapy eliminates detectable metastatic kidney tumor in adolescent after multiple relapses - Medical Xpress

An Experimental Pediatric Cancer Treatment Shows Promise in New Research - Time Magazine

Legend interim CEO talks rising competition as Carvykti maker posts first profit - fiercepharma.com

Navigating Second-Line CAR-T Candidacy and Sequencing in DLBCL - CancerNetwork

Ultrasound-guided SHIFTERS could expand CAR-T therapy for solid tumors - News-Medical

These Overlooked Immune Cells Supercharge the Fight Against Cancer - SciTechDaily

In vivo CRISPR screen identifies gene edits that strengthen CAR-T therapy against solid tumors - Medical Xpress

T-Mobile vs. Verizon: Which Major Phone Carrier Works Best for You? - CNET

SpaceX claims Starlink Mobile will be better than AT&T, T-Mobile, and Verizon - Ars Technica

Stem Cell : 2026August14Friday

Billionaire Home Depot cofounder Bernie Marcus’ foundation donates nearly $30 million toward stem cell research for heart attacks - Yahoo

Cancer Stem Cells Have an “Energy Addiction” – and Scientists Found a Way To Exploit It - SciTechDaily

Lacking 'sense of time': organoid and real brain compared - ERC

TNFR1 signaling connects inflammation to impaired fatty acid oxidation to drive intestinal stem cell aging - Nature

Without this protein, damaged muscle turns to fat and scar tissue - ScienceDaily

Reversible epiblast regionalization determines differentiation potential of human pluripotent stem cells - Nature

Human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease: a phase 1/2 open-label trial - Nature

Student Story: My journey into stem cell conservation - Cornell University College of Veterinary Medicine

Vanillin flavoring in e-cigarettes disrupts human embryonic stem cell development - University of California, Riverside

Marcus Foundation donates nearly $30 million toward research for stem cell for heart attacks - Fortune

Biomedical: 2026August14Friday

Maine IDeA Network of Biomedical Research Excellence celebrates its 25th year - WABI

University of New Haven Undergraduate Advances Biomedical Research and Prepares for Graduate Studies - University of New Haven

Foundation models in biomedical imaging: turning hype into reality - Nature

Enigma Biomedical USA Announces FDA Approval of TAUKLARIFY™ (florquinitau F 18 injection) for Use in Patients Being Evaluated for Alzheimer’s Disease - Business Wire

UC Davis Engineers Collaborate on Rare Epilepsy Study - UC Davis College of Engineering

Veterinary students expand horizons into biomedical research through summer program in 19th year - Virginia Tech News

For biomedical engineering students, Italy became the classroom - University of Miami News

USPTO Expands Category A Patent Bar Admission Criteria to Include Biomedical Science Degree - IPWatchdog.com

Houston VA Biomedical Engineer Named to 2026 TechNation 40 Under 40 | VA Houston health care | Veterans Affairs - VA.gov Home | Veterans Affairs

Acro Biomedical (ACBM) flags going concern risk amid cash shortage and no revenue - Stock Titan

Biotechnology : 2026August14Friday

Mechanistic machine learning for prediction of prime editing outcomes - Nature

Zealand Pharma sells rusfertide royalties for $100 million - The Pharma Letter

Boan Biotechnology Advances First-in-Class CD228 ADC With Positive Early Trial Data - TipRanks

Proteome-wide identification of the druggable CRBN interactome - Nature

Discovery and design of potent cell surface display elements - Nature

Light up your space with glowing houseplants - Nature

Mapping and engineering the human cell–cell interactome - Nature

IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics - PR Newswire

RAPID-446 : Autonomous Lab for Biotechnology - anl.gov

ARCH venture funds disclose 15%+ Sana Biotechnology (SANA) ownership in updated filing - Stock Titan